InvestorsHub Logo
Followers 60
Posts 3833
Boards Moderated 0
Alias Born 05/25/2021

Re: None

Wednesday, 05/08/2024 4:12:09 PM

Wednesday, May 08, 2024 4:12:09 PM

Post# of 699055
I can feel there is close coordination between NWBO and Oncovir.

The enemy is often one we can’t see, and sometimes the enemy is hiding in plain sight. Many dangers avoid detection until it is too late. Cancerous tumors are certainly one such enemy. Matthew Vandermast, President and COO of Oncovir, explains, “So when you have an immunologically cold tumor, it means that the tumor has evaded your body’s base immune system. Cancer has immunologic evasions that allow it to grow unchecked within the body. And what you’ll see in cold tumors is an immunological desert, there aren’t enough immune cells, including T-cells, available in those areas for your body to fight against the cancer.”



https://www.oncovir.com/new-page

https://gritdaily.com/cancer-therapy-oncovirs-hiltonol/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News